| Type | Title | Date Released | |
|---|---|---|---|
4 | Gruninger Marc (Reporting) | ||
4 | Ziegler Christoph Samuel (Reporting) | ||
6-K | VERAXA Biotech Presents In Vivo Proof-of-Concept Data for BiTAC-ADC Technology at World ADC Congress | ||
3 | Willener Raju Sudir (Reporting) | ||
424B3 | UPDATE TO PRIOR PROSPECTUS | Shares: 139,732,124 | ||
424B3 | UPDATE TO PRIOR PROSPECTUS | Shares: 25,000,000 | ||
6-K | VERAXA Biotech Appoints Raju Willener as Chief Financial Officer | ||
4 | Baumann Oliver Rolf (Reporting) | ||
4 | Antz Christoph Rudiger (Reporting) | ||
6-K | VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance | ||
3 | von Halem Carl (Reporting) | ||
SCHEDULE 13G/A | AQR CAPITAL MANAGEMENT LLC (Filed by) |
